Glenmark Shells Out Another $25m To Resolve Civil Price-Fixing Charges

 
• By Dave Wallace

Glenmark Pharmaceuticals agreed to pay $25m in the US to resolve its alleged liability under the False Claims Act linked to price-fixing allegations.

Glenmark logo on website under magnifying glass
Glenmark has agreed to pay $25m to resolve civil claims. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics